Sagaliam Acquisition Corp. announced that it has amended the executed non-binding term sheet for the purchase of Biogenysis Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. amending the combined purchase price to $450,000,000. Additionally, the company announce that Ronnie Richardson, Krystine Miller, and Travis Richardson are joining Board of Directors.